논문 목록
Issue Date Title Journals
2024-03 Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study Targeted Oncology
2023-10 Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer British Journal of Cancer
2023-05 Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment Cancers
2023-05 TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway Nature communications
2023-05 High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer Oncology reports
2023-03 Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer Frontiers in Oncology
2023-02 High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer International Journal of Molecular Sciences
2022-11 TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis Cancer Genomics and Proteomics
2022-11 RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer JOURNAL OF GENE MEDICINE
2022-10 NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells Journal of Cellular and Molecular Medicine
2022-07 Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients AMERICAN JOURNAL OF CANCER RESEARCH
2022-05 NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59 SCIENTIFIC REPORTS
2022-02 Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models Cancers
2021-11 CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer CANCER GENOMICS & PROTEOMICS
2021-07 Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial EXPERIMENTAL AND THERAPEUTIC MEDICINE
2021-05 Clinical significance of tumor infiltrating lymphocytes in association with hormone receptor expression patterns in epithelial ovarian cancer International Journal of Molecular Sciences
2021-05 The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
2021-04 LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells AUTOPHAGY
2021-01 MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors PLOS PATHOGENS
2020-05 TOM40 inhibits ovarian cancer cell growth by modulating mitochondrial function including intracellular ATP and ROS levels Cancers
2020-05 Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer CANCER GENOMICS & PROTEOMICS
2020-01 HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors NATURE COMMUNICATIONS
2019-12 Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer BMC CANCER
2019-11 Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer CANCER GENOMICS & PROTEOMICS
2019-11 Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
2019-10 ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer Cancers
2019-06 Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth INTERNATIONAL JOURNAL OF HYPERTHERMIA
2018-10 Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression PLOS ONE
2018-08 Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance JOURNAL OF CLINICAL INVESTIGATION
2018-08 DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer Cancers
2018-07 Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models. CANCER RESEARCH AND TREATMENT
2018-05 Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas Obstetrics & Gynecology Science
2018-05 Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer. GYNECOLOGIC ONCOLOGY
2018-05 Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis CANCER RESEARCH
2018-02 Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
2018-02 Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF CELL DEATH AND DIFFERENTIATION
2017-09 API5 induces cisplatin resistance through FGFR signaling in human cancer cells EXPERIMENTAL AND MOLECULAR MEDICINE
2017-09 HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. CANCER RESEARCH
2017-09 Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer ANTICANCER RESEARCH
2017-01 REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival CELL DEATH & DISEASE
2017-01 Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement JOURNAL OF GYNECOLOGIC ONCOLOGY
2016-10 A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue. LABORATORY INVESTIGATION
2016-07 Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer ONCOTARGET
2016-05 The paraffin-embedded RNA metric (PERM) for RNA isolated from formalin-fixed, paraffin-embedded tissue BIOTECHNIQUES
2016-05 Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer YONSEI MEDICAL JOURNAL
2016-02 Over-expression of BMI1 is associated with favorable prognosis in cervical cancer INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
2016-01 Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology MEDICINE
2015-12 Clinical significance of OCT4 and SOX2 protein expression in cervical cancer BMC CANCER
2015-11 Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. ONCOTARGET
2015-10 Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer PATHOBIOLOGY
2015-07 PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. NATURE COMMUNICATIONS
2015-05 Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array DIAGNOSTIC PATHOLOGY
2014-12 MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. BMC CANCER
2014-11 ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer YONSEI MEDICAL JOURNAL
2014-09 A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2014-07 Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer BMC CANCER
2014-06 The role of S100A14 in epithelial ovarian tumors ONCOTARGET
2014-06 Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer PLOS ONE
2014-04 Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer GENES CHROMOSOMES & CANCER
2013-11 Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer BIOMARKERS
2013-11 Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer. CANCER INVESTIGATION
2013-08 Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. JOURNAL OF TRANSLATIONAL MEDICINE
2013-07 Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. HUMAN PATHOLOGY
2013-04 Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer HUMAN PATHOLOGY
2013-03 The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia Obstetrics & Gynecology Science
2013-02 Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia OBSTETRICS AND GYNECOLOGY
2012-11 Nanog signaling in cancer promotes stem-like phenotype and immune evasion JOURNAL OF CLINICAL INVESTIGATION
2012-01 Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
2012-01 Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: A case-control study EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
2011-12 로봇을 이용한 자궁근종절제술의 유용성: 복강경 그리고 개복수술과 비교 대한산부인과학회지